These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 458249)

  • 1. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
    Angles-Cano E; Sultan Y; Clauvel JP
    J Lab Clin Med; 1979 Aug; 94(2):312-23. PubMed ID: 458249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of fibrinolysis in systemic lupus erythematosus].
    Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):184-90. PubMed ID: 2427400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.
    Awada H; Barlowatz-Meimon G; Dougados M; Maisonneuve P; Sultan Y; Amor B
    J Lab Clin Med; 1988 Feb; 111(2):229-36. PubMed ID: 3123585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody and immune complexes induce tissue factor production by human endothelial cells.
    Tannenbaum SH; Finko R; Cines DB
    J Immunol; 1986 Sep; 137(5):1532-7. PubMed ID: 3745915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
    Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clotting defect in SLE.
    Byron MA
    Clin Rheum Dis; 1982 Apr; 8(1):137-51. PubMed ID: 6811189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
    Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
    J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.
    Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI
    J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
    Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
    J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.
    Jurado M; Páramo JA; Gutierrez-Pimentel M; Rocha E
    Thromb Haemost; 1992 Nov; 68(5):516-20. PubMed ID: 1455397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis.
    Dhillon PK; Adams MJ
    Semin Thromb Hemost; 2013 Jun; 39(4):434-40. PubMed ID: 23504607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.